The Pharmacology of the Insulinomimetic Effect of Zinc Complexes
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In developing new insulinomimetic zinc(II) complexes with different coordination structures and with a blood glucose-lowering effect to treat type 2 diabetic animals, we found a potent bis(maltolato)zinc(ll) complex, Zn(mal)(2). Using the complex as the leading compound, we examined the in vitro and in vivo structure-activity relationships of Zn(mal)(2) and its related complexes in respect to the inhibition of free fatty acids (FFA) release and the enhancement of glucose uptake in isolated rat adipocytes treated with epinephrine (adrenaline), and hypoglycemic activity. Among the compounds tested, a new Zn(II) complex with allixin that was isolated from garlic, bis(allixinato)Zn(II), Zn(alx)(2), was found to exhibit the highest insulin-mimetic and hypoglycemic activities in type 2 KK-A(y) diabetic mice. On the basis of the results, Zn(alx)(2), complex was proposed to be a potent candidate for the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An adequate supply of zinc is crucial for insulin biosynthesis and storage, especially when there is hyperglycemia. In zinc-deficient states, there is a clear decrease in islet cell insulin content (80, 81).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [81]
Citations
Cites
Insulin-like Effect of Zinc on Adipocytes
Coulston, L., & Dandona, P. (1980) · Diabetes · doi:10.2337/diab.29.8.665 · Cited by 213 · cited 1×
“A finding in 1980 that zinc(II) chloride (ZnCl2) stimulated lipogenesis in rat adipocytes similarly to the action of insulin (Coulston & Dandona 1980) prompted many researchers to demonstrate the compound as an insulin mime.”
BackgroundNAKAI, M., WATANABE, H., FUJIWARA, C., KAKEGAWA, H., SATOH, T., TAKADA, J., MATSUSHITA, R., & SAKURAI, H. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.719 · Cited by 169 · cited 1×
“In in vitro evaluation, we used simple and convenient test systems composed of examining suppression of free fatty acids (FFA) release from the adipocytes (Nakai et al. 1995) and the enhancement of glucose uptake in the cells treated with epinephrine (adrenaline) (Adachi & Sakurai 2004).”
MethodSelf-citationChen, M.-D., Liou, S.-J., Lin, P.-Y., Yang, V. C., Alexander, P. S., & Lin, W.-H. (1998) · Biological Trace Element Research · doi:10.1007/bf02789090 · Cited by 166 · cited 2×
“1992) and type 2 diabetic ob/ob mice in 1998 (Chen et al. 1998).”
BackgroundMethodA New Concept: The Use of Vanadium Complexes in the Treatment of Diabetes Mellitus
Sakurai, H. (2002) · The Chemical Record · doi:10.1002/tcr.10029 · Cited by 164 · cited 3×
“After many trials, we have proposed several types of potent Zn(II) complexes, as shown in Table 1 (Sakurai 2002), as potential insulin mimes.”
BackgroundMethodSelf-citationThe mechanism of the insulin-like effects of ionic zinc.
May, J. M., & Contoreggi, C. S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34730-6 · Cited by 161
Ilouz, R., Kaidanovich, O., Gurwitz, D., & Eldar-Finkelman, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00636-8 · Cited by 160 · cited 3×
“Zn(II) has been examined since 1982, with respect to glucose oxidation and lipolysis stimulation (James & Charles 1982), glucose transport and glycogen synthesis (Ezaki 1989), and inhibition of endogenous glycogen synthase kinase-3b (Ronit et al. 2002).”
BackgroundShisheva, A., Gefel, D., & Shechter, Y. (1992) · Diabetes · doi:10.2337/diab.41.8.982 · Cited by 141 · cited 1×
“After many trials, ZnCl2 was found to improve the hyperglycemia of type 1 diabetic mice in 1992 (Shisheva et al. 1992) and type 2 diabetic ob/ob mice in 1998 (Chen et al. 1998).”
MethodEzaki, O. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71594-9 · Cited by 119 · cited 2×
“Previously, researchers found that the Zn(II) effect on both glucose oxidation and lipolysis stimulation was due to the inhibitionof catalase (May&Contoreggi 1982), and in a later study it was found that Zn(II) stimulated both lipogenesis and glucose transport in the adipocytes (Ezaki 1989).”
BackgroundYoshikawa, Y., Ueda, E., Kawabe, K., Miyake, H., Takino, T., Sakurai, H., & Kojima, Y. (2001) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100266 · Cited by 118 · cited 1×
“In a colorless single crystal of [Zn(6mpa)2(H2O)]H2O (bis(6methylpicolinato)Zn(II)) (Yoshikawa et al. 2002), the coordination geometry was a distorted trigonal hipyramidal structure.”
BackgroundSelf-citationAdachi, Y., Yoshida, J., Kodera, Y., Kato, A., Yoshikawa, Y., Kojima, Y., & Sakurai, H. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0590-8 · Cited by 86 · cited 4×
“in reference to the systemas an ensemblemechanism (Adachi et al. 2004).”
BackgroundMethodSelf-citationThe action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes
Yoshikawa, Y., Ueda, E., Kojima, Y., & Sakurai, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.02.006 · Cited by 81 · cited 1×
“By comparing the obtained results on ZnSO4, Zn(pic)2, Zn(mal)2, and Zn(thr)2 (bis(threoninato)Zn(II)), we found that such Zn(II) complexes seemed to promote the glucose uptake into the adipocytes by affecting simultaneously at least three sites in the adipocytes (Yoshikawa et al. 2004).”
ResultSelf-citationYoshikawa, Y., Ueda, E., Kawabe, K., Miyake, H., Sakurai, H., & Kojima, Y. (2000) · Chemistry Letters · doi:10.1246/cl.2000.874 · Cited by 79 · cited 3×
“A colorless single crystal of Zn(mal)2 (bis(maltolato)Zn(II)) (11) was determined to be trans-[Zn(mal)2(H2O2)][Zn(mal)2(H2O)](H2O)2 by X-ray structure analysis (Yoshikawa et al. 2000), revealing the occurrence of two different geometries around the Zn atoms with octahedral and Table 1 insulinomimetic Zn(II) complexes…”
BackgroundMethodSelf-citationAdachi, Y., & Sakurai, H. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.428 · Cited by 44 · cited 1×
“In in vitro evaluation, we used simple and convenient test systems composed of examining suppression of free fatty acids (FFA) release from the adipocytes (Nakai et al. 1995) and the enhancement of glucose uptake in the cells treated with epinephrine (adrenaline) (Adachi & Sakurai 2004).”
MethodSelf-citation
Research works printed but not linked: 1
- MD Chen, 1998, Biol Trace Elem Res, 61, 301
Cited by
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
“In zinc-deficient states, there is a clear decrease in islet cell insulin content (80,81).”
BackgroundPillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 775
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Zinc and diabetes — clinical links and molecular mechanisms
Jansen, J., Karges, W., & Rink, L. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.009 · Cited by 439
“Insulinomimetic activity of these complexes was strongly related to lipophilicity of the ligands, indicating that the complex has to reach intracellular space [97,100].”
BackgroundDietary and Physiological Effects of Zinc on the Immune System
Wessels, I., Fischer, H. J., & Rink, L. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122019-120635 · Cited by 205
Metadata
- Authors
- Sakurai, H., & Adachi, Y.
- Affiliations
- Kyoto Pharmaceutical University (JP)
- Corresponding author
- Sakurai, Hiromu
- Venue
- BioMetals
- Published
- 2005-08
- Volume
- 18
- Issue
- 4
- Pages
- 319-323
- ISSN
- 0966-0844 (ISSN-L)
- 1572-8773
- OpenAlex
- W2016305315
- Cited by
- 76
- References
- 13
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 8 · 2014: 1 · 2013: 4 · 2012: 6
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- BioMetals (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- zinc(II) complexes, type 2 diabetes, hypoglycemic activity, glucose uptake, free fatty acid release, adipocytes, epinephrine, structure-activity relationship
- MeSH terms
- Animals, Blood Glucose, Body Weight, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Disease Models, Animal, Epinephrine, Fatty Acids, Nonesterified, Glucose, Glucose Tolerance Test, Humans, Insulin, Ligands, Models, Chemical, Organometallic Compounds, Time Factors, Zinc, Zinc Compounds, Inhibitory Concentration 50, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.